Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-06

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approves a supplemental application for nicardipine hydrochloride (generic) submitted by Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)